Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Off-label Use of Medical Devices in Cardiovascular Medicine—When the Final Decision About the Safety and Effectiveness Is Needed Kapitel lesen Erstes Kapitel lesen

2019 | OriginalPaper | Buchkapitel

Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic

verfasst von : Denisa Horáková, Gleb Donin

Erschienen in: World Congress on Medical Physics and Biomedical Engineering 2018

Verlag: Springer Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The purpose of this study was to carry out the economic evaluation of robotic stereotactic body radiation therapy (rSBRT) in comparison with conventional intensity-modulated radiation therapy (IMRT) for the treatment of localized prostate cancer in the Czech Republic. Cost-utility analysis was used for the economic evaluation of both technologies based on their costs and the number of quality-adjusted life years gained (QALYs). Utilities of both technologies were identified in literature. An estimation of treatment costs was obtained from publicly available secondary sources for the Czech Republic. The cost-utility analysis was conducted from provider’s perspective for three scenarios (optimistic, realistic, and pessimistic). According to the results of cost-utility analysis, in every scenario concerned IMRT was both more effective and less costly than rSBRT. Namely, in realistic scenario, IMRT and rSBRT accrued 9.96 QALY/53,198 CZK and 9.93 QALY/79,956 CZK, respectively. rSBRT reached the same or lower values of the cost-utility ratio than IMRT in situation, when the acquisition price of rSBRT equipment was lower than CZK 58 million in the realistic scenario. Under the conditions of the Czech healthcare system, IMRT was more cost-effective than rSBRT for localized prostate cancer treatment in all the analyzed scenarios.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Cost-Effectiveness Analysis of Intrabeam System Introduction to the Czech Healthcare System Environment
Nächstes Kapitel Usability of Volume Pulse Wave Biosignal
Literatur
1.
IHIS: Cancer Incidence in the Czech Republic, 2015. Institute of Health Information and Statistics of the Czech Republic, Prague (2017).
2.
Brenner, D.J., Martinez, A.A., Edmundson, G.K., Mitchell, C., Thames, H.D., Armour, E.P.: Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue. Int. J. Radiat. Oncol. 52, 6–13 (2002).
3.
Fowler, J., Chappell, R., Ritter, M.: Is α/β for prostate tumors really low? International Journal of Radiation Oncology Biology Physics. 50(4), 1021–1031 (2001).
4.
Moon, D.H., Efstathiou, J.A., Chen, R.C.: What is the best way to radiate the prostate in 2016? Urologic oncology. 35(2), 59–68 (2017).
5.
Avkshtol, V., Dong, Y., Hayes, S.B., Hallman, M.A., Price, R.A., Sobczak, M.L., Horwitz, E.M., Zaorsky, N.G.: A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Research and reports in urology. 8, 145–158 (2016).
6.
Parthan, A., Pruttivarasin, N., Davies, D., Taylor, D.C.A., Pawar, V., Bijlani, A., Lich, K.H., Chen, R.C.: Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer. Frontiers in oncology. 2, 81 (2012).
7.
Hodges, J.C., Lotan, Y., Boike, T.P., Benton, R., Barrier, A., Timmerman, R.D.: Costeffectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. Journal of oncology practice. 8(3S), e31 s–7 s (2012).
8.
Yu, J.B., Cramer, L.D., Herrin, J., Soulos, P.R., Potosky, A.L., Gross, C.P.: Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 32(12), 1195–1201 (2014).
9.
Sher, D.J., Parikh, R.B., Mays-Jackson, S., Punglia, R.S.: Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer. American journal of clinical oncology. 37(3), 215–221 (2014).
10.
Laviana, A.A., Ilg, A.M., Veruttipong, D., Tan, H.-J., Burke, M.A., Niedzwiecki, D.R., Kupelian, P.A., King, C.R., Steinberg, M.L., Kundavaram, C.R., Kamrava, M., Kaplan, A.L., Moriarity, A.K., Hsu, W., Margolis, D.J.A., Hu, J.C., Saigal, C.S.: Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer. Cancer. 122, 447–455 (2016).
11.
Halpern, J.A., Sedrakyan, A., Hsu, W.-C., Mao, J., Daskivich, T.J., Nguyen, P.L., Golden, E.B., Kang, J., Hu, J.C.: Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. Cancer. 122, 2496–2504 (2016).
12.
13.
Sharieff, W., Greenspoon, J.N., Dayes, I., Chow, T., Wright, J., Lukka, H.: The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer: A Comparison of Dose Regimens and Delivery Systems. Technology in cancer research & treatment. 15(1), 171–178 (2016).
14.
Ministerstvo zdravotnictví ČR: Národní radiologické standardy - radiační onkologie. Věstník Ministerstva zdravotnictví. 2, 62–202 (2016).
15.
Krupa, P., Šlampa, P.: Moderní radikální radioterapie karcinomu prostaty a její možná rizika. Postgraduální medicína. 2, 65–69 (2016).
16.
Cvek, J., Knybel, L., Otáhal, B., Feltl, D.: Možnosti stereotaktického ozáření páteře a míchy přístrojem CyberKnife. Onkologie. 5(2), 83–86 (2011).
17.
James, S.: A guide to modern radiotherapy. Society of Radiographers, London (2013).
18.
19.
U.S. Securities and Exchange Commission: Accuray CyberKnife® Shared Ownership Agreement. (2017).
20.
21.
Ohinmaa, A.: Cost estimation of stereotactic radiosurgery: application to Alberta. Edmonton, Canada (2003).
22.
Calcerrada, N., Sabés, R.: Efectividad, seguridad y estimación de costes del sistema de radiocirugía CyberKnife. Unidad de Evaluación de Tecnologías Sanitarias (UETS), Agencia Laín Entralgo, Madrid (2005).
23.
Zukalová, V.: Klasifikace a oceňování radioterapeutických zdravotnických přístrojů, Master Thesis, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno (2017).
24.
25.
Gutiérrez-Ibarluzea, I., Gutiérrez Iglesias, A., Galnares Cordero, L., Shengelia Shapiro, L., Boveda Carro, E., Celeiro González, J., Bilbao Zulaica, P., Bayon Yusta, J.: Evaluación de radioterapia conformada con haces de intesidad modulada. IMRT. Ministerio de Sanidad, Servicios Sociales e Igualdad. Servicio de Evaluación de Tecnologías Sanitarias del País Vasco, Vitoria-Gasteiz (2014).
26.
Yong, J.H.E., McGowan, T., Redmond-Misner, R., Beca, J., Warde, P., Gutierrez, E., Hoch, J.S.: Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario. Current Oncology. 23(3), e228–e238 (2016).
27.
28.
IHIS: Zdravotnická ročenka České republiky 2015. Institute of Health Information and Statistics of the Czech Republic, Prague (2017).
29.
Briggs, A.H., Gray, A.M.: Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 319, 635–8 (1999).
30.
Skoupá, J., Annemans, L., Hájek, P.: Health Economic Data Requirements and Availability in the European Union: Results of a Survey Among 10 European Countries. Value in Health Regional Issues. 4(7), 53–57 (2014).
31.
Drummond, M., Barbieri, M., Cook, J., Glick, H.A., Lis, J., Malik, F., Reed, S.D., Rutten, F., Sculpher, M., Severens, J.: Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value in Health. 12 (4), 409–418 (2009).
Metadaten
Titel
Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic
verfasst von
Denisa Horáková
Gleb Donin
Copyright-Jahr
2019
Verlag
Springer Singapore
Buch
World Congress on Medical Physics and Biomedical Engineering 2018

Print ISBN: 978-981-10-9037-0

Electronic ISBN: 978-981-10-9038-7

Copyright-Jahr: 2019

DOI
https://doi.org/10.1007/978-981-10-9038-7_20

Neuer Inhalt

    Bildnachweise